Author:
Klarenbeek Sjoerd,van Miltenburg Martine H.,Jonkers Jos
Funder
European Union
Top Institute (TI) Pharma
TI Center for Translational Molecular Medicine (CTMM)
Netherlands Organization for Scientific Research (NWO)
Cancer Systems Biology Center and the Dutch Cancer Society (KWF)
Subject
Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology
Reference151 articles.
1. Delayed mammary gland involution in MMTV-AKT1 transgenic mice;Ackler;Oncogene,2002
2. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation;Adams;Cancer Res.,2011
3. Subtle variations in Pten dose determine cancer susceptibility;Alimonti;Nat. Genet.,2010
4. Phase I study of everolimus plus weekly paclitaxel and trastuzumab in patients with metastatic breast cancer pretreated with trastuzumab;Andre;J. Clin. Oncol.,2010
5. TAMRAD: a GINECO randomized phase II trial of everolimus in combination with tamoxifen versus tamoxifen alone in patients (pts) with hormone-receptor positive, HER2 negative metastatic breast cancer (MBC) with prior exposure to aromatase inhibitors (AI);Bachelot;Cancer Res.,2011
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献